Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study
AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study
AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study
Submitted by
admin
on February 9, 2016 - 9:00am
Source:
Fierce Biotech
News Tags:
AstraZeneca
durvalumab
tremelimumab
metastatic non-small cell lung cancer
Headline:
AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study
Do Not Allow Advertisers to Use My Personal information
